PT ETHICA Industri Farmasi’s new manufacturing site is equipped with the latest pharmaceutical technologies for the sterile manufacturing of injectable drugs. The company has invested around Rp. 1 trillion in the new production plant. The new plant will manufacture a wide range of injectable drugs. Thereby, the company will contribute to the government’s goal to transform Indonesia into one of the most important manufacturing centers for pharmaceutical products for Asia, Australia, and further markets around the globe.
Cikarang, 23 November 2017 – Today, the Indonesian Minister of Health Prof. Dr. Dr. Nila Djuwita F. Moeloek has inaugurated the new production plant of PT ETHICA Industri Farmasi, a joint venture between Fresenius Kabi AG and SOHO Global Health. The new plant was constructedon a 4.3 hectare greenfield site located in the Jababeka Industrial Complex, Cikarang, West Java. PT ETHICA Industri Farmasi has investedapproximately Rp.1 trillion to set up the plant for the manufacturing ofinjectable drugs in ampoules and vials using aseptic and terminal sterilization technologies.PT ETHICA Industri Farmasi employs approximately230 people at the new production plant.